US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments.
about
US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
US Food and Drug Administratio ...... and Radiographic Assessments.
@en
US Food and Drug Administratio ...... and Radiographic Assessments.
@nl
type
label
US Food and Drug Administratio ...... and Radiographic Assessments.
@en
US Food and Drug Administratio ...... and Radiographic Assessments.
@nl
prefLabel
US Food and Drug Administratio ...... and Radiographic Assessments.
@en
US Food and Drug Administratio ...... and Radiographic Assessments.
@nl
P2093
P2860
P356
P1476
US Food and Drug Administratio ...... and Radiographic Assessments.
@en
P2093
Amna Ibrahim
Erik Bloomquist
Geoffrey Kim
Julia A Beaver
Kirsten B Goldberg
Laleh Amiri-Kordestani
Paul Kluetz
Rajeshwari Sridhara
Richard Pazdur
P2860
P304
P356
10.1200/JCO.2017.74.6917
P407
P577
2018-03-09T00:00:00Z